Evidence map›Paper›PMID 34100399›Full record

ArticleIndian journal of pharmacology

Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica.

Ashish Aditya, Paritosh Amar, Anjuman Chander, Nitika Goel, Kajal Jain, Tanvir Samra

Open access · greenAbstract readCase Reports
In one paragraph

Article in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ashish AdityaDepartment of Anesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Paritosh AmarDepartment of Anesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Anjuman ChanderDepartment of Anesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Nitika GoelDepartment of Anesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Kajal JainDepartment of Anesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Tanvir SamraDepartment of Anesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calculation of the maximum recommended dose of local anesthetic minimizes the risk of Local Anesthetic Systemic Toxicity (LAST) when administrating multiple blocks for lower limb surgeries. Ropivacaine is the preferred local anesthetic as it is less lipophilic than bupivacaine and thus results in less central nervous system (CNS) and cardiovascular toxicity. The presence of developmental, congenital, and metabolic disorders mandates an extracautious approach in the administration of large volume of Local anaesthesia (LA) as the vascularity of the limb, levels of alpha-1-acid glycoprotein, and sensitivity of the sodium channels may be altered. This case report highlights successful resuscitation of a patient with Phacomatosis pigmentokeratotica after the development of CNS toxicity secondary to the administration of ropivacaine in ultrasound-guided combined lumbar plexus and sciatic nerve block. We identified some high risk patient profiles which should be vigilantly monitored to minimize the incidence of LAST.

Indexed as

Anesthetics, LocalHumansMaleNevus, PigmentedRopivacaineSkin NeoplasmsYoung AdultAnesthetics, LocalRopivacaineBupivacainelidocainelipid emulsionlocal anestheticphacomatosis pigmentokeratoticaropivacaine

Identifiers

PMID34100399
PMCPMC8265418
OpenAlexW3165695537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.